Modulation of IAPs for the diagnosis and antisense treatment of proliferative disease

Patent Citations (8)

Non-Patent Literature (66)

• Andrea Branch, A good antisense molecule is hard to find. TIBS, vol. 23, Feb. 1998, pp. 45-50.Applicant
• Birnbaum et al., “An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs,” J. of Virol., 68:2521, (1994).Applicant
• Branch, “A good antisense molecule is hard to find,” TIBS p. 45-46 (1998).Applicant
• Campbell, Monoclonal Antibody Technology, Elsevier Science, Publishers B.V. New York, NY, (1984).Applicant
• Cheng et al., “Staurosporine, K-252a, and K-252b stabilize calcium homeostasis and promote survival of CNS neurons in the absence of glucose,” J. Neurochem., 62:1319-1329, (1994).Applicant
• Clem et al., “Anti-apoptotic genes of baculovirus,” Cell Death and Differentiation, 3:9-16, (1996).Applicant
• Clem et al., “Induction and inhibition of apoptosis by insect viruses,” Apoptosis II: The Molecular Basis of Apoptosis in Disease, Cold Spring Harbor Laboratory Press, p. 89, (1994).Applicant
• Clem et al., “Prevention of apoptosis by a baculovirus gene during infection of insect cells,” Science 254:1388, (1991).Applicant
• Clem et al., “Control of programmed cell death by the baculovirus genes p35 and IAP,” Mol. and Cell. Biology, 14:5212, (1994).Applicant
• Crocker et al., “Adenovirus-mediated NAIP overexpression confers protection against global ischemia,” Database Biosis, Abstract, (1996).Applicant
• Crook et al., “An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif,” J. of Virol., 67:2168, (1993).Applicant
• Dhein et al., “Autocrine T-cells suicide mediated by APO-1 (Fas/CD95),” Abstract, Nature, 373:438, (1995).Applicant
• Duckett et al., “A conserved family of cellular genes related to the baculovirus IAP gene and encoding apoptosis inhibitors,” The EMBO Journal, 15:2685-2694, (1996).Applicant
• Femandez et al., “Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: Induction of bcl-2, c-myc, and manganese superoxide dismutase in resistant cells,” Abstract, Oncogene, 9:2009, (1994).Applicant
• Ferrari et al., “N-acetylcysteine (D-and L-stereoisomers) prevents apoptotic death of neuronal cells,” Abstract, J. Neurosci., 1516:2857, (1995).Applicant
• Fisher et al., “Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome,” Cell, 81:935, (1995).Applicant
• Francis et al., “The Response of GABAergic and cholinergic neurons to transient cerebral ischemia,” Brain Res., 243:271-278, (1982).Applicant
• Gibellini et al., “Tat-expression jurkat cells show an increased resistance to different apoptic stimuli, including acute human immunodeficiency virus-type 1,” Abstract, Br. J. Haematol., 89:24, (1995).Applicant
• Glicksman et al., “K-252a and staurosporing promote choline acetyltransferawe activity in rat spinal cord Cultures,” J. Neurochem., 61:210-221, (1993).Applicant
• Glicksman et al., “K-252a analog prevents developmentally programmed motoneuron death and the loss of chat activity in adult motoneurons in vivo,” Soc. Neuro. Abst., 441, (1994).Applicant
• Glicksman et al., “K-252a promotes survival and choline acetyltransferase activity in straital and basal forebrain neuronal cultures,” J. Neurochem., 64:1502-1512, (1995).Applicant
• Golstein et al., “Homology between reaper and the cell death domains of Fas and TNFR1,” Cell 81:185, (1995).Applicant
• Goruppi et al., “Dissection of c-myc domains involved in S phase induction of NIH3T3 fibroblasts,” Abstract, Oncogene, 9:1537, (1994).Applicant
• Harrington et al., “c-Myc-induced apoptosis in fibroblasts is inherited by specific cytokines,” Abstract, EMBO J. 13:3286, (1994).Applicant
• Itoh et al., “A novel protein required for proptosis. Mutational analysis of human Fas antigen,” Abstract, J. Biol. Chem., 268:10932, (1993).Applicant
• Katsikis et al., “Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals,” Abstract, J. Exp. Med., 1815:2029, (1995).Applicant
• Kerr, “Neglected opportunities in apoptosis research,” Trends in Cell Biology, 5:55, (1995).Applicant
• Korsmeyer, “Regulators of cell death,” TIG 11:101, (1995).Applicant
• Li et al.,“Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein,” Abstract, Science, 268:429, (1995).Applicant
• Liston et al., “Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes,” Nature, 397:349-353, (1996).Applicant
• Martin et al., “HIV-1 infection of human CD4+ T cells in vitro. Differential induction of apoptosis in these cells,” Abstract, J. Immunol., 152:330, (1994).Applicant
• Melino et al., “Tissue transglutaminase and apoptosis: Sense and antisense transfection studies with human neuroblastoma cells,” Abstract, Mol. Cell. Biol., 14:6584, (1994).Applicant
• Murayama et al., “Immunocytochemical and ultrastructural studies of Werdnig-Hoffmann disease,” Acta Neuropathol., 81:408-41, (1991).Applicant
• Muro-Cacho et al., “Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphold tissue and not with stage of disease or viral burden,” Abstract, J. Immunol., 154:5555, (1995).Applicant
• Nakanshi et al., “K-252a, a noval microbial product, inhibits smooth muscle myosin light chain kinase,” J. Biol. Chem., 23:6215-6219, (1988).Applicant
• Nunez et al., “The Bcl-2 family of proteins: regulators of cell death and survival,” Trends in Cell Biology, 4:399, (1994).Applicant
• Osborne et al., “Essential genes that regulate apoptosis,” Trends in Cell Biology, 4:394, (1994).Applicant
• Peterson et al.,“Loss of GABAergic neurons in medial septum after fimbria-fornix transection,” Neurosci. Lett., 76:140-144, (1987).Applicant
• Pulsinelli et al., “Temporal profile of neuronal damage in a model of transient forebrain ischemia,” Ann. Neurol., 11:491-498, (1982).Applicant
• Rabizadeh et al., “Expression of the baculovirus p35 gene inhibits mammalian neural cell death,” Abstract. J. Neurochem., 61:2318, (1993).Applicant
• Ridoux et al., “The use of adenovirus vectors for intracerebral grafting of transfected nervous cells,” Neuroreport., 5(7):801-804, (1994).Applicant
• Ridoux et al., “Adenoviral vectors as functional retrograde neuronal tracers,” Brain Res., 648(1):171-175, (1994).Applicant
• Ridoux et al., “Ex vivo culture of adult microglial cells from previously lesioned rat brains,” C.R. Acad. Sci. III, 317(3):217-224, (1994).Applicant
• Rieux-Laucat et al., “Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity,” Science, 268:1347, (1995).Applicant
• Robertson et al., “Neuroprotective effects of K252a in cerebral ischemia: The NAIP connection,” Database Biosis Abstract (1996).Applicant
• Rosenbaum et al., “Evidence for hypoxia-induced, programmed cell death of cultured neurons,” Abstract, Ann. Neurol., 376:864, (1994).Applicant
• Rothe et al., “The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins,” Cell, 83:1243-1252, (1995).Applicant
• Roy et al., “The gene for neuronal apoptosis inhibitory protein in partially deleted in individuals with spinal muscular atrophy,” Cell, 80:167, (1995).Applicant
• Sato et al., “Neuronal differentiation of PC12 cells as a result of prevention of cell death by bcl-2,” Abstract, J. Neurobiol., 25:1227, (1994).Applicant
• Sauer et al., “Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat,” Neuroscience, 59(2):401-415, (1994).Applicant
• Semba et al., “Organization of central cholinergic systems,” Progress in Brain Res., 79:36-63, (1989).Applicant
• Smith-Swintosky et al., “K252A, K252B and staurosporine increase hippocampal neuron survival and improve water maze performance after kainate,” Soc. Neuro. Abst., 2130, (1995).Applicant
• Steiman et al., “Infantile neuronal degeneration masquerading as Werdnig-Hoffmann disease,” Ann. Neurol., 8:317-324, (1980).Applicant
• Steller, “Mechanisms and genes of cellular suicide,” Science, 267:1445, (1995).Applicant
• Talley et al., “Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: Protection by the antioxidant N-acetylcysteine and the genes bcl-2 And crmA,” Abstract, Mol. Cell. Biol., 1585:2359, (1995).Applicant
• Terai et al., “Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1,” Abstract, J. Clin. Invest., 87:1710, (1991).Applicant
• Tetzlaff et al., “Changes in cytoskeletal proteins in the rat facial nucleus following axotomy,” J. Neurosci. 8(9):3181-3189, (1988).Applicant
• Towfighi et al., “Is Werdnig-Hoffman disease a pure lower motor neuron disorder?,” Acta Neuropathol., 65:270-280, (1985).Applicant
• Vossbeck et al., “Direct transforming activity of TGF-beta on rat fibroblasts,” Abstract. Int. J. Cancer, 61:92, (1995).Applicant
• Walkinshaw et al., “Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease,” Abstract, J. Clin. Invest. 95:2458, (1995).Applicant
• Westendorp et al., “Sensitization of T cells to CD95-mediated apoptosis by HIV-1 tat and gp 120,” Nature, 375:497, (1995).Applicant
• White et al., “Genetic control of programmed cell death in Drosphila,” Science, 264:677, (1994).Applicant
• Williams et al., “Apoptosis: final control point in cell biology,” Trends in Cell Biology 2:263. (1992).Applicant
• Wylie, “Death gets a brake,” Nature, 369:272, (1994).Applicant
• Xu et al., “Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus,” Nature Medicine 3(9):997-1004, (1997).Applicant
• Xu et al., “Distribution of neuronal apoptosis inhibitory protein-like immunoreactivity in the rat central nervous system,” The Journal of Comparative Neurology 382:247-259, (1997).Applicant